Vaccine safety - is the SARS-CoV-2 vaccine any different?
Vaccines have changed modern medicine, and are a mainstay in reducing morbidity and mortality from infections. Our research group recently published a study in which we found that vaccines approved by the US Food and Drugs Administration were safe with few clinically important post-approval adverse...
Saved in:
Main Authors: | Noam Tau (Author), Dafna Yahav (Author), Daniel Shepshelovich (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024) -
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023) -
Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023) -
T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022) -
SARS-CoV-2 and prematurity. Any evidence of vertical transmission?
by: Elena María Márquez Isidro, et al.
Published: (2021)